在质母细胞瘤病因学中BRCA1的作用
Emirhan Harbi1, Michael Aschner2
1Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY, 10461, USA. emirhanharbi41@gmail.com.
质母细胞瘤中的BRCA1基因变异会损害DNA修复,推动瘤生长和治疗耐药性. 针对BRCA1通路,包括PARP抑制剂,为这种具有挑战性的癌症提供了新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- BRCA1 (乳腺癌1) 是一种关键的瘤抑制基因,通过同源重组 (HR) 和基因组稳定性参与DNA修复.
- 在乳腺癌,前列腺癌和卵巢癌中,BRCA1的作用已被确立,但其在质母细胞瘤中的重要性越来越被认可.
研究的目的:
- 审查与BRCA1相关的质母细胞瘤的病因机制和潜在治疗方法.
- 讨论BRCA1失调对质母细胞瘤进展和治疗耐药性的影响.
主要方法:
- 对研究BRCA1表达,功能和治疗向质母细胞瘤的研究进行文献综述.
- 分析BRCA1,p53,PTEN和其他分子途径在质母细胞瘤发病过程中的相互作用.
主要成果:
- 改变BRCA1表达,虽然很少见,但与质母细胞瘤的预后不佳和攻击性增加有关.
- BRCA1失调会损害DNA修复,导致瘤的进展和对放射治疗和化疗等标准疗法的耐药性.
- 聚 (ADP-ribose) 聚合酶 (PARP) 抑制剂通过利用BRCA1突变质母细胞瘤中的HR缺陷来显示治疗潜力.
结论:
- 准与BRCA1相关的途径是一个有前途的策略,可以提高质母细胞瘤治疗的疗效.
- 质母细胞瘤的异质性及其瘤微环境对这些向疗法的临床转化提出了重大挑战.
- 对于与BRCA1相关的质母细胞瘤有效治疗的急性未满足需求.
更多相关视频
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
相关概念视频
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancers Originate from Somatic Mutations in a Single Cell
Mitogens and the Cell Cycle
The Ras Gene
Ras is a...
